Evidence map›Paper›PMID 38865173›Full record

ArticleJMIR mHealth and uHealth2024

Mobile Health App and Web Platform (eDOL) for Medical Follow-Up of Patients With Chronic Pain: Cohort Study Involving the French eDOL National Cohort After 1 Year.

Noémie Delage, Nathalie Cantagrel, Sandrine Soriot-Thomas, Marie Frost, Rodrigue Deleens, Patrick Ginies, Alain Eschalier, Alice Corteval, Alicia Laveyssière, Jules Phalip and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in JMIR mHealth and uHealth, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04880096 (Constitution and Analysis of a Cohort of Patients Followed in Pain Clinics and at Home in Real Life), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04880096 recruitingnot on this map

Constitution and Analysis of a Cohort of Patients Followed in Pain Clinics and at Home in Real Life

TypeobservationalSponsorUniversity Hospital, Clermont-FerrandRan2021 to 2026Enrolled5,000ConditionsChronic PainArmseDOL
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Noémie DelageCentre d'évaluation et de Traitement de la douleur, CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0001-6671-1911
Nathalie CantagrelCentre d'évaluation et de Traitement de la douleur, CHU Toulouse, Toulouse, France.ORCID https://orcid.org/0000-0001-9290-9905
Sandrine Soriot-ThomasCentre de Recherche Clinique, CHU Amiens Picardie, Amiens, France.ORCID https://orcid.org/0009-0004-7114-3700
Marie FrostCentre d'évaluation et de Traitement de la douleur, CHU Grenoble, Grenoble, France.ORCID https://orcid.org/0000-0003-2314-7358
Rodrigue DeleensCentre d'évaluation et de Traitement de la douleur, CHU Rouen, Rouen, France.ORCID https://orcid.org/0000-0001-5546-2657
Patrick GiniesCentre d'évaluation et de Traitement de la douleur, CHU Montpellier, Montpellier, France.ORCID https://orcid.org/0000-0001-7994-3578
Alain EschalierAnalgesia Institute, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0001-6778-1057
Alice CortevalAnalgesia Institute, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0002-2172-6375
Alicia LaveyssièreAnalgesia Institute, Clermont-Ferrand, France.ORCID https://orcid.org/0009-0008-1305-9235
Jules PhalipAnalgesia Institute, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0002-1118-4226
Célian BertinService de pharmacologie médicale, CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0002-2393-7061
Bruno PereiraDirection de la recherche clinique et de l'innovation, CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0003-3778-7161
Chouki ChenafService de pharmacologie médicale, CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID https://orcid.org/0009-0006-2534-3765
Bastien DoreauLaboratoire d'Informatique, de Modélisation et d'Optimisation des Systèmes, Université Clermont Auvergne, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0002-0114-1986
Nicolas AuthierService de pharmacologie médicale, CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0002-1236-0383
ePAIN *See Acknowledgments, , France.
Nicolas KerckhoveService de pharmacologie médicale, CHU Clermont-Ferrand, Clermont-Ferrand, France.ORCID https://orcid.org/0000-0003-2223-1240

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChronic pain affects approximately 30% of the general population, severely degrades quality of life and professional life, and leads to additional health care costs. Moreover, the medical follow-up of patients with chronic pain remains complex and provides only fragmentary data on painful daily experiences. This situation makes the management of patients with chronic pain less than optimal and may partly explain the lack of effectiveness of current therapies. Real-life monitoring of subjective and objective markers of chronic pain using mobile health (mHealth) programs could better characterize patients, chronic pain, pain medications, and daily impact to help medical management.

objectiveThis cohort study aimed to assess the ability of our mHealth tool (eDOL) to collect extensive real-life medical data from chronic pain patients after 1 year of use. The data collected in this way would provide new epidemiological and pathophysiological data on chronic pain.

methodsA French national cohort of patients with chronic pain treated at 18 pain clinics has been established and followed up using mHealth tools. This cohort makes it possible to collect the determinants and repercussions of chronic pain and their evolutions in a real-life context, taking into account all environmental events likely to influence chronic pain. The patients were asked to complete several questionnaires, body schemes, and weekly meters, and were able to interact with a chatbot and use educational modules on chronic pain. Physicians could monitor their patients' progress in real time via an online platform.

resultsThe cohort study included 1427 patients and analyzed 1178 patients. The eDOL tool was able to collect various sociodemographic data; specific data for characterizing pain disorders, including body scheme; data on comorbidities related to chronic pain and its psychological and overall impact on patients' quality of life; data on drug and nondrug therapeutics and their benefit-to-risk ratio; and medical or treatment history. Among the patients completing weekly meters, 49.4% (497/1007) continued to complete them after 3 months of follow-up, and the proportion stabilized at 39.3% (108/275) after 12 months of follow-up. Overall, despite a fairly high attrition rate over the follow-up period, the eDOL tool collected extensive data. This amount of data will increase over time and provide a significant volume of health data of interest for future research involving the epidemiology, care pathways, trajectories, medical management, sociodemographic characteristics, and other aspects of patients with chronic pain.

conclusionsThis work demonstrates that the mHealth tool eDOL is able to generate a considerable volume of data concerning the determinants and repercussions of chronic pain and their evolutions in a real-life context. The eDOL tool can incorporate numerous parameters to ensure the detailed characterization of patients with chronic pain for future research and pain management.

trial registrationClinicalTrials.gov NCT04880096; https://clinicaltrials.gov/ct2/show/NCT04880096.

Indexed as

Chronic PainMobile ApplicationsAdultAgedCohort StudiesFemaleFollow-Up StudiesFranceHumansInternetMaleMiddle AgedQuality of LifeSurveys and QuestionnairesTelemedicinechronic paineHealthmHealthmobile healthobservational studyself-monitoring

Identifiers

PMID38865173
PMCPMC11208841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.